Xue et al. revealed that GAS5 overexpression in prostate cancer cells can significantly reduce the phosphorylation of AKT and its downstream proteins mTOR and S6K1 through targeting miR-103 [23]. This evidence concerns the gene GAS5 and prostate cancer.